Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Josh Disbrow
AddedMar 31, 2024
UpdatedMay 31, 2026
Josh Disbrow

Josh Disbrow

Board Member, Ampio Pharmaceuticals

CrunchbaseLinkedIn

Josh Disbrow's Career

Ampio Pharmaceuticals
Ampio Pharmaceuticals

Englewood, CO, US

Board Member· Board
Aytu BioPharma
Aytu BioPharma

Englewood, CO, US

Board Member· Board
Zynex
Zynex

Englewood, CO, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Josh Disbrow's Career

Ampio Pharmaceuticals
Ampio Pharmaceuticals

Englewood, CO, US

Board Member· Board
Aytu BioPharma
Aytu BioPharma
Public$36M1642015Englewood, CO, US
Board Member· Board

Leadership at Aytu BioPharma

John A DonofrioJohn A DonofrioBoard Member
Vivian LiuVivian LiuBoard Member

Similar to Aytu BioPharma

UroGen PharmaUroGen PharmaNew York City, NY, USPharmaceuticalsest. 2004UroGen PharmaNew York City, NY, US · est. 2004

UroGen Pharma Ltd.: A clinical-stage biopharmaceutical firm innovating therapies for uro-oncology.

Public · $422.1M200
Harmony BiosciencesHarmony BiosciencesPlymouth Meeting, PA, USPharmaceuticalsest. 2017Harmony BiosciencesPlymouth Meeting, PA, US · est. 2017

Harmony Biosciences: Innovating therapies for rare neurological disorders in the U.S.

Public · $1.2B200
Zynex
Zynex
Public$53.7M9001996Englewood, CO, US
Board Member· Board

Leadership at Zynex

Thomas SandgaardThomas SandgaardBoard Member
Barry MichaelsBarry MichaelsBoard Member
Michael CressMichael CressBoard Member

Similar to Zynex

Zenith Technical InnovationsZenith Technical InnovationsGurnee, IL, USMedical Devicesest. 2014Zenith Technical InnovationsGurnee, IL, US · est. 2014

Zenith Technical Innovations: Illinois-based medical device manufacturer and distributor, specializing in versatile therapy solutions.

Seed · $3.1M3
Nexeon MedsystemsNexeon MedsystemsDallas, TX, USMedical Devicesest. 2015Nexeon MedsystemsDallas, TX, US · est. 2015

Nexeon MedSystems: Global provider of neurostimulation medical devices enhancing patients' lives.

Public · $30.3M62
SynerZ MedicalSynerZ MedicalSt. Louis, MO, USMedical Devicesest. 2013SynerZ MedicalSt. Louis, MO, US · est. 2013

SynerZ Medical, Inc.: A St. Louis-based medical device company specializing in obesity and type 2 diabetes treatment.

Seed · $1.7M5
ZSX MedicalZSX MedicalPhiladelphia, PA, USMedical Devicesest. 2009ZSX MedicalPhiladelphia, PA, US · est. 2009

ZSX Medical, LLC: Innovating minimally-invasive surgery with Zip-stitch, a surgical closure system enhancing patient outcomes.

Series A · $3.7M11

Josh Disbrow's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Josh Disbrow

David BorishDavid BorishBoard Member · neo 360Jordan DolesJordan DolesCo-Founder · NeuroX InnovationsDon HardisonDon HardisonBoard Member · HTG Molecular DiagnosticsTom WilderTom WilderBoard Member · Vensana CapitalTim KutzkeyTim KutzkeyBoard Member · SurrozenPaul L. BernsPaul L. BernsBoard Member · Unity Biotechnology